文献速递儿童心血管与肾脏儿童神经与发育行为

单心室心脏病中纤维化相关基因表达

Fibrosis-Related Gene Expression in Single Ventricle Heart Disease.
PubMed 文献 · J Pediatr · 2017-10-16

本研究对单心室心脏病伴右心室衰竭的儿科患者及非衰竭对照的右心室心肌进行实时定量PCR和组织学纤维化评估。结果显示衰竭单心室心肌中胶原(Col1α、Col3)表达降低,stage III中TIMP-1、TIMP-3、TIMP-4下调,而MMP-2、MMP-9无差异;组织学右心室纤维化患病率在衰竭组(18%)与正常功能组(38%)间无差异。结论认为纤维化不是婴幼儿单心室心脏病右心室衰竭的主要贡献因素。

要点

  • 单心室心脏病伴衰竭者右心室心肌胶原Col1α和Col3表达降低。
  • Stage III患者TIMP-1、TIMP-3、TIMP-4表达下调,MMP-2、MMP-9无差异。
  • 组织学右心室纤维化患病率在衰竭组与正常功能组间无差异。

核心结论

  • 纤维化不是婴幼儿单心室心脏病右心室衰竭的主要贡献因素。
  • 需要进一步研究抗纤维化治疗在该人群中的获益。

研究设计与样本

  • 对单心室心脏病儿科患者及非衰竭心脏病对照的离体右心室心肌进行实时定量聚合酶链反应。
  • 受试者分为单心室衰竭组、单心室非衰竭组和stage III组,并比较年龄和右心室容量负荷相似的对象。
  • 对所有心脏进行组织学纤维化评估,采用Mann-Whitney检验比较基因表达差异。

主要发现

  • 单心室先心病伴衰竭者胶原Col1α和Col3表达较非衰竭单心室先心病降低(P = .019和P = .035)。
  • Stage III组TIMP-1、TIMP-3和TIMP-4较非衰竭右心室心脏病下调(P = .0047、P = .013和P = .013)。
  • MMP-2和MMP-9在非衰竭与衰竭单心室心脏病间及stage III与非衰竭右心室心脏病间相似。
  • 组织学右心室纤维化患病率在单心室衰竭伴右心室衰竭者(18%)与右心室功能正常者(38%)间无差异。

关键数值与推荐

  • 单心室衰竭组胶原Col1α表达较非衰竭单心室组降低,P = .019。
  • 单心室衰竭组胶原Col3表达较非衰竭单心室组降低,P = .035。
  • Stage III组TIMP-1表达较非衰竭右心室心脏病下调,P = .0047。
  • Stage III组TIMP-3表达较非衰竭右心室心脏病下调,P = .013。
  • Stage III组TIMP-4表达较非衰竭右心室心脏病下调,P = .013。

临床怎么用

  • 对于婴幼儿单心室心脏病右心室衰竭,纤维化可能不是主要机制,抗纤维化治疗需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate fibrosis and fibrosis-related gene expression in the myocardium of pediatric subjects with single ventricle with right ventricular failure. STUDY DESIGN: Real-time quantitative polymerase chain reaction was performed on explanted right ventricular myocardium of pediatric subjects with single ventricle disease and controls with nonfailing heart disease. Subjects were divided into 3 groups: single ventricle failing (right ventricular failure before or after stage I palliation), single ventricle nonfailing (infants listed for primary transplantation with normal right ventricular function), and stage III (Fontan or right ventricular failure after stage III). To evaluate subjects of similar age and right ventricular volume loading, single ventricle disease with failure was compared with single ventricle without failure and stage III was compared with nonfailing right ventricular disease. Histologic fibrosis was assessed in all hearts. Mann-Whitney tests were performed to identify differences in gene expression. RESULTS: Collagen (Col1α, Col3) expression is decreased in single ventricle congenital heart disease with failure compared with nonfailing single ventricle congenital heart disease (P = .019 and P = .035, respectively), and is equivalent in stage III compared with nonfailing right ventricular heart disease. Tissue inhibitors of metalloproteinase (TIMP-1, TIMP-3, and TIMP-4) are downregulated in stage III compared with nonfailing right ventricular heart disease (P = .0047, P = .013 and P = .013, respectively). Matrix metalloproteinases (MMP-2, MMP-9) are similar between nonfailing single ventricular heart disease and failing single ventricular heart disease, and between stage III heart disease and nonfailing right ventricular heart disease. There is no difference in the prevalence of right ventricular fibrosis by histology in subjects with single ventricular failure heart disease with right ventricular failure (18%) compared with those with normal right ventricular function (38%). CONCLUSIONS: Fibrosis is not a primary contributor to right ventricular failure in infants and young children with single ventricular heart disease. Additional studies are required to understand whether antifibrotic therapies are beneficial in this population.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Nakano SJ, Siomos AK, Garcia AM, et al. Fibrosis-Related Gene Expression in Single Ventricle Heart Disease. J Pediatr. 2017. PMID: 29050751. doi:10.1016/j.jpeds.2017.08.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。